Saturday, September 22, 2018 8:41:19 AM
The date of this prospectus supplement is September 21, 2018.
Settlement Agreement
On September 8, 2018, we entered into a Confidential Settlement Agreement and Release, or the Settlement Agreement, with Multicell Immunotherapeutics, Inc., or Multicell, to settle a breach of contract lawsuit. As part of the Settlement Agreement, we agreed to issue to Multicell 75,000 shares of Common Stock at an agreed value of $2.00 per share. Multicell is a selling stockholder. For purposes of the table below, beneficial ownership is based on the securities held of record by the selling stockholders as of May 11, 2018.
https://ir.gtbiopharma.com/all-sec-filings/content/0001654954-18-010380/0001654954-18-010380.pdf
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM